Andrew Stewart

Andrew Stewart

Rothwell, Figg, Ernst & Manbeck, P.C.

Contact
View Bio
RSS

Latest Posts › BPCIA

Share:

Continued Investment in AI Drug Discovery Points to Potential Future Significance of Inventorship in Biosimilar Litigation

On December 3, 2024, Bristol Myers Squibb announced a collaboration agreement with three-year-old startup AI Proteins. According to its founder, Chris Bahl, PhD, AI Proteins uses “AI, synthetic biology, and laboratory...more

12/20/2024  /  Artificial Intelligence , Biosimilars , BPCIA , Inventors , Investment , Patent Litigation , Patents , Prescription Drugs , Research and Development , USPTO

New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Market

On November 17, 2023, Genentech, Hoffman-La Roche, and Biogen (collectively “plaintiffs”) filed a complaint in the federal district court for the District of New Jersey against Dr. Reddy’s Laboratories and Fresenius Kabi...more

12/4/2023  /  Biosimilars , BPCIA , Food and Drug Administration (FDA) , Patent Infringement , Pharmaceutical Patents , Popular
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide